Non-Contact Monitoring of Subjects With an Optical Device: A Pilot Usability Study
NCT ID: NCT04182165
Last Updated: 2020-07-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2019-12-10
2020-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will be divided into two arms:
First Arm - Subjects measured by the study staff via the investigational device at the hospital (up to 50 subjects).
Second Arm - subjects measuring themselves autonomously with the investigational device at their homes (up to 10 subjects from the first arm).
Hence, total number of subjects for the study will be up to N=50. All subjects will be enrolled to the study only after signing an informed consent form.
Specifically for the second arm, subjects will undergo proper training by the sponsor's representatives prior to being discharged from the hospital. Training will focus on proper operation of the device, which is also designed for autonomous use in a simple and user-friendly manner. Subjects will be asked to monitor themselves periodically for a duration of up to a week. Ongoing support will be provided by the sponsor upon subject request, either by phone, or on-premise via a dedicated support team.
For both arms, device users (either study staff in first arm or subjects in the second arm) will be requested to answer questionnaires in order to assess usability with the investigational device. In both cases, a dedicated sponsor representative will observe the users to gather objective usability data, and aid in the questionnaire filling process.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Analysis of a Non-contact Respiratory and Heart Rate Monitor Vs. a Conventional Clinically Validated Reference Monitor
NCT04179279
BioButton Among Nursing Home Residents
NCT06665685
Novel Self-charging, Medical-Grade Smart Insoles With AI/ML Edge Computing to Monitor Biometrics.
NCT07273422
Study to Verify the Feasibility of Collecting a Broad Variety of Individual Health Data
NCT03135678
Indirect Evaluation of Lithium Level in Blood Using Non-invasive Sweat Biosensors
NCT04186507
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subjects measured by the study staff
Subjects measured by the study staff via the investigational device at the hospital (up to 50 subjects).
Gili BioSensor System/ Gili Pro X BioSensor System
Usability study
Subjects measuring themselves autonomously
Subjects measuring themselves autonomously with the investigational device at their homes (up to 10 subjects from the first arm).
Gili BioSensor System/ Gili Pro X BioSensor System
Usability study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gili BioSensor System/ Gili Pro X BioSensor System
Usability study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hemodynamically stable as assessed by the investigator
Exclusion Criteria
* Inability to provide informed consent
* Parallel participation in another clinical study
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ContinUse Biometrics Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tel Aviv Sourasky Medical Center (TASMC)
Tel Aviv, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CUBX-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.